| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.008 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.008 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.009 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.009 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |